Gerard Cantero Recasens I am a Principal Investigator of the Renal Physiopathology Group at Vall d'Hebron Research Institute (VHIR) in Barcelona. Motivated by my deep interest in understanding how ion signalling impacts cellular homeostasis and its pathological implications, I have cultivated over the years a diverse skill set including electrophysiology, biochemistry, live-cell imaging, molecular biology, and cell biology. My primary research focus lies in unravelling the intricate relationship between ion homeostasis, glycosylation, and protein trafficking under both physiological and pathological conditions, with a particular emphasis on renal diseases. Instituciones de las que forman parte Investigador/a principal Fisiopatología Renal Vall Hebron Institut de Recerca Email Gerard Cantero Recasens Email Instituciones de las que forman parte Investigador/a principal Fisiopatología Renal Vall Hebron Institut de Recerca I am a Principal Investigator of the Renal Physiopathology Group at Vall d'Hebron Research Institute (VHIR) in Barcelona. Motivated by my deep interest in understanding how ion signalling impacts cellular homeostasis and its pathological implications, I have cultivated over the years a diverse skill set including electrophysiology, biochemistry, live-cell imaging, molecular biology, and cell biology. My primary research focus lies in unravelling the intricate relationship between ion homeostasis, glycosylation, and protein trafficking under both physiological and pathological conditions, with a particular emphasis on renal diseases.
I conducted my Ph.D. thesis in Dr. Valverde’s lab (UPF) on the role of different asthma-associated proteins in controlling intracellular Ca2+ levels. During my Ph.D., I collaborated with Dr. von Blume (USA) to identify a new sorting mechanism at the Golgi; and with Dr. Hoth’s Lab (Germany) to hone my electrophysiological Ca2+ measurement techniques. Later, as a postdoctoral researcher in Dr. Malhotra’s lab (CRG), I led a team that unravelled how cells regulate mucins’ quality and quantities. From 2020 to 2022, I served as a senior researcher of the Renal Physiopathology Group (VHIR), where I studied the role of ion channels in rare renal diseases. Recently, I have been a visiting researcher at the Osaka International Cancer Institute, to deepen my knowledge on glycosylation (Japan); and at Leiden University (the Netherlands) to learn renal organoids’ generation. My expertise in the field of ion channels is shown by my presentations at numerous scientific congresses and my high-impact publications (74 citations/year in the last 5 years). At present, I am director of a Ph.D. thesis and two Master Final Projects. Regarding my teaching experience, currently, I am professor of the Translational Biomedical Research Master at VHIR, where I am also the co-coordinator of the cardiovascular and kidney diseases module. My involvement in the scientific community also includes being a member of the Dent Disease Foundation Medical Advisory Board (USA), review editor of Frontiers in Cell and Developmental Biology, and national and international grants’ evaluator. Referring to my merits, I was awarded with a Spanish Ph.D. mobility fellowship, the extraordinary Ph.D. award, a Juan de la Cierva fellowship, and a short-term EMBO fellowship. Furthermore, I have secured national and international funding, including grants from the Instituto de Salud Carlos III, the Mizutani Foundation for Glycoscience and the "Sociedad Española Contra el Cáncer".
Proyectos La variabilidad fenotípica en pacientes afectados de Hipomagnesemia Familiar con Hipercalciuria y Nefrocalcinosis (HFHNC) como oportunidad para entender las bases fisiopatológicas de la enfermedad y para la búsqueda de soluciones terapéuticas IP: Anna Meseguer Navarro Colaboradores: Gema Ariceta Iraola, Gerard Cantero Recasens Entidad financiadora: Sociedad Española de Nefrología (S.E.N.) Financiación: 24000 Referencia: SENEFRO/PROJECTES/2023/MESEGUER Duración: 27/11/2023 - 26/11/2025 Fucosylation in Clear Cell Renal Cell Carcinoma. STATing novel biomarkers and therapeutic strategies IP: Anna Meseguer Navarro Colaboradores: Gerard Cantero Recasens, Miriam Izquierdo Sans Entidad financiadora: Asociación Española Contra el Cáncer Financiación: 150000 Referencia: INVES234762CANT Duración: 15/11/2023 - 14/11/2026 Papel del ClC-5 en la fibrosis renal. Identificación de posibles biomarcadores y dianas terapéuticas para la progresión de la enfermedad de Dent 1 IP: Gerard Cantero Recasens Colaboradores: Anna Meseguer Navarro, Hector Rios Duro, Gloria Mª Fraga Rodriguez, Julieta Torchia, Julieta Torchia Entidad financiadora: Instituto de Salud Carlos III Financiación: 123420 Referencia: PI22/00741 Duración: 01/01/2023 - 31/12/2025 Patologia Cel·lular IP: Anna Meseguer Navarro Colaboradores: Gema Ariceta Iraola, Alejandro Cruz Gual, Gerard Cantero Recasens, David Lorente García, Marina Muñoz López, Hector Rios Duro, Luis Augusto Castro Sáder, Gloria Mª Fraga Rodriguez, Julieta Torchia Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 40000 Referencia: 2021 SGR 01600 Duración: 01/01/2022 - 30/06/2025 Paginación Página actual 1 Página 2 Siguiente página › Última página »
